FIELD: veterinary. SUBSTANCE: proposed composition contains, mass %: 4-(indanyl-2)pyridine hydrochloride 25-40, hydrophile biosoluble polymer 63-55, polyvinylpyrrolidone 5-12. Proposed composition is manufactured as film having prolonged action. EFFECT: improves quality of desired product.
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR ANTIOXIDANT PROTECTION OF EYE MEDIA AND TISSUES | 1993 |
|
RU2070010C1 |
| AGENT FOR PLATELET AGGREGATION DECREASE IN CIRCULATORY SYSTEM | 1995 |
|
RU2095064C1 |
| AGENT FOR FLUORESCENT DIAGNOSIS AND PHOTODYNAMIC THERAPY ON ONCOLOGICAL AND NON-ONCOLOGICAL DISEASES | 2002 |
|
RU2219921C1 |
| BIOLOGIALLY ACTIVE AGENT HAVING EFFECT ON GENERAL METABOLIC, EXCITATORY AND INHIBITORY NERVE FUNCTION AND INTELLECTUAL MNESTIC CEREBRAL FUNCTIONS (VERSIONS) | 2011 |
|
RU2461374C1 |
| METHOD FOR CARRYING OUT MEDICAL TREATMENT OF PROGRESSIVE AND COMPLICATED MYOPIA | 2000 |
|
RU2192261C2 |
| PROLONGED MEDICINAL FORMS OF LOCAL ACTION WHICH PRODUCE ACTIVATING IMPACT UPON IMMUNE SYSTEM | 2001 |
|
RU2185807C1 |
| MEANS WITH ANTISTRESS, ANXIOLYTIC AND ANTIDEPRESSANT ACTIVITY AND COMPOSITION BASED THEREON | 2015 |
|
RU2617512C1 |
| PERCUTANEOUS DELIVERY SYSTEM, USING MICROPOROUS MEMBRANE CONTAINING PORES FILLED WITH SOLVENT | 2018 |
|
RU2789194C2 |
| PROLONGED MEDICINAL FORMS OF LOCAL ACTION WHICH PRODUCE ANTIBACTERIAL AND IMMUNOACTIVATING CAPACITY | 2001 |
|
RU2185806C1 |
| TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
